Khodamoradi Zohre, Pakfetrat Maryam, Torabinezhad Simin, Sagheb Mohammad Mahdi
Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Department of Nephrology, Nephro-Urology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
J Nephropathol. 2017 Jul;6(3):225-230. doi: 10.15171/jnp.2017.37. Epub 2017 Apr 20.
Acute interstitial nephritis (AIN) is an emerging cause of acute kidney injury (AKI) during the recent years.
There is no data about prevalence, causes, clinical manifestation and outcomes of AIN in our region. Hence, in this study we aimed to find the prevalence of AIN and describe the causes, clinical presentation, and the outcome of AIN in the native kidney biopsies.
We reviewed 934 native kidney biopsies from 2006 to 2014 and collected the data of patients with the diagnosis of AIN including medical history, clinical findings, para-clinical data, pathologic findings, treatment and outcomes.
Prevalence of AIN in our center during 2006 to 2014 was 2.5% of all renal biopsies. The common cause of AIN in our study was drugs. Of those patients admitted to hospital due to AIN, 17 patients (70.8%) received corticosteroid, five of them (29.4%) received pulse of corticosteroid, and 12 patients (70.6%) received oral drug. Around, 54.2% of the patients had hemodialysis during admission. Eight patients had received both dialysis and corticosteroid. Two of them (8.3%) remained on dialysis and 8 (33.3%) developed chronic kidney disease, but 14 (58.3%) patients recovered.
The prevalence of AIN in our study is comparable to other studies and we found the great impact of medications on development of AIN.
急性间质性肾炎(AIN)是近年来急性肾损伤(AKI)的一个新出现的病因。
我们所在地区尚无关于AIN的患病率、病因、临床表现及转归的数据。因此,在本研究中,我们旨在确定AIN的患病率,并描述其在肾活检中的病因、临床表现及转归。
我们回顾了2006年至2014年的934例肾活检病例,并收集了诊断为AIN的患者的数据,包括病史、临床检查结果、辅助检查数据、病理检查结果、治疗及转归。
2006年至2014年期间,我们中心AIN在所有肾活检病例中的患病率为2.5%。本研究中AIN的常见病因是药物。因AIN入院的患者中,17例(70.8%)接受了皮质类固醇治疗,其中5例(29.4%)接受了皮质类固醇冲击治疗,12例(70.6%)接受了口服药物治疗。约54.2%的患者在住院期间接受了血液透析。8例患者同时接受了透析和皮质类固醇治疗。其中2例(8.3%)仍需透析,8例(33.3%)发展为慢性肾脏病,但14例(58.3%)患者康复。
我们研究中AIN的患病率与其他研究相当,且我们发现药物对AIN的发生有很大影响。